Literature DB >> 8341599

Activation of HIV-specific ribozyme activity by self-cleavage.

M Ventura1, P Wang, T Ragot, M Perricaudet, S Saragosti.   

Abstract

A hammerhead ribozyme designed to cleave in trans the R region of HIV-1 RNA was inserted into a eukaryotic expression vector. This ribozyme was studied in vitro using the T3 RNA polymerase promoter located upstream of the eukaryotic promoter. The ribozyme showed no activity against its specific target sequence under any condition tested. To decrease the influence of potential cis inhibitory sequences in such a ribozyme transcript, a specific target sequence was inserted upstream of the ribozyme-coding sequence. This insertion allowed the release by cis cleavage of a short RNA bearing ribozyme activity and able to cleave in trans an external RNA target. The cis cleavage reaction generated two RNA molecules: the shorter RNA species, which included the catalytic domain, showed a trans cleavage reaction. This self-cleavable ribozyme was active in vitro at 37 degrees C against three distinct HIV-1 transcripts sharing the specific target sequence. Ribozyme activity was thus attained by self-cleavage of the ribozyme-containing sequence from the longer vector transcript.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341599      PMCID: PMC309763          DOI: 10.1093/nar/21.14.3249

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.

Authors:  N R Taylor; B E Kaplan; P Swiderski; H Li; J J Rossi
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  A method for generating transcripts with defined 5' and 3' termini by autolytic processing.

Authors:  M Altschuler; R Tritz; A Hampel
Journal:  Gene       Date:  1992-12-01       Impact factor: 3.688

3.  Construction of a tRNA-embedded-ribozyme trimming plasmid.

Authors:  N Yuyama; J Ohkawa; Y Inokuchi; M Shirai; A Sato; S Nishikawa; K Taira
Journal:  Biochem Biophys Res Commun       Date:  1992-08-14       Impact factor: 3.575

Review 4.  Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

Authors:  J J Rossi; N Sarver
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

5.  Ribozymes correctly cleave a model substrate and endogenous RNA in vivo.

Authors:  S K Saxena; E J Ackerman
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

6.  Construction of a novel artificial-ribozyme-releasing plasmid.

Authors:  K Taira; M Oda; H Shinshi; H Maeda; K Furukawa
Journal:  Protein Eng       Date:  1990-08

7.  LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.

Authors:  S Wain-Hobson; J P Vartanian; M Henry; N Chenciner; R Cheynier; S Delassus; L P Martins; M Sala; M T Nugeyre; D Guétard
Journal:  Science       Date:  1991-05-17       Impact factor: 47.728

8.  Influence of the surface potential on the purple membrane structure and activity.

Authors:  M E Rivière; B Arrio; R Pansu; J Faure
Journal:  Arch Biochem Biophys       Date:  1991-01       Impact factor: 4.013

9.  Self-cleavage of virusoid RNA is performed by the proposed 55-nucleotide active site.

Authors:  A C Forster; R H Symons
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

10.  Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo.

Authors:  P Steinecke; T Herget; P H Schreier
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  6 in total

1.  Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library.

Authors:  A Lieber; M Strauss
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  Generation of circular RNAs and trans-cleaving catalytic RNAs by rolling transcription of circular DNA oligonucleotides encoding hairpin ribozymes.

Authors:  A M Diegelman; E T Kool
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

4.  High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes.

Authors:  M Eloit; M Adam; I Gallais; A Fournier
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.

Authors:  J D Thompson; D F Ayers; T A Malmstrom; T L McKenzie; L Ganousis; B M Chowrira; L Couture; D T Stinchcomb
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

6.  A ribozyme targeted to cleave the polymerase gene sequences of different foot-and-mouth disease virus (FMDV) serotypes.

Authors:  Y Stram; T Molad
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.